OUP Webinar: Finding Your Startup CEO
Friday, June 21, 2024 - 12:00pm to 1:00pmJoin Osage University Partners (OUP) for a two-part webinar series on finding a CEO for your academic startup company. We will hold the first part of this webinar series on June 21st and will focus on the evaluation process for CEO candidates. OUP Managing Partner Marc Singer will discuss the importance of the leadership team to a startup’s success and explore methods for evaluating outside CEOs. The webinar will highlight relevant backgrounds and important characteristics of a startup CEO, and it will provide tools to assist with candidate evaluation. Marc will also provide data on the performance of different types of CEOs, including grad students and professors, from OUP’s tech portfolio.
The second part of the webinar series will be held later this summer and will focus on sourcing of the CEO and other C-suite talent. OUP Managing Partner Matt Cohen will moderate a panel featuring a recruiter, a talent professional from a VC firm, and a serial academic entrepreneur. Dates and additional information coming soon.
Register here.
Small Business Transition Grant Q&A Webinar
Thursday, June 20, 2024 - 2:00pm to 3:00pmNCI SBIR Program director Saroj Regmi will be hosting a virtual Q&A session on the Small Business Transition Grant. Following a brief overview on this funding opportunity, Saroj will answer attendee questions.
The Small Business Transition Grant was developed to assist early-career academic scientists in transitioning to entrepreneurship. Beginning as a Phase I STTR award that transitions into a Phase II SBIR award, it provides innovators with up to $2.4 million towards their biotech R&D efforts. As of this year’s Notice (RFA-CA-24-023), the Small Business Transition Grant has also expanded to include a Phase I STTR-only option. Applications are due Monday, August 21, 2024 by 5:00 p.m. ET.
Join Saroj's virtual webinar to learn more.
Antibody and Bioresource Core Facility Services
Thursday, June 20, 2024 - 12:00pm to 1:00pmThe Antibody and Bioresource Core Facility (ABCF) supports researchers by making it easier for them to develop new monoclonal antibodies (MAbs). As an informational resource as well as service provider, the facility collaborates closely with faculty from MSK and Rockefeller University. It also supports Weill Cornell Medicine researchers as third-party clients.
Attend this virtual interview to discover more about the core facility and how it can support your project. The 45-min interview will be followed by a 15-minute Q&A session for the audience.
Join us to discover ABCF’s resources and capabilities, including:
- Generating custom MAbs
- Distributing cell lines and hybridomas developed at MSK and RU
- Performing mycoplasma testing
Interviewers
Loren A. Busby, CFA, Director, Weill Cornell Medicine BioVenture eLab
Carlo Yuvienco, PhD, Director, Ford Center Incubator @ The Rockefeller University
Featured Guest
Frances Weis-Garcia, PhD ’96, Director, Bi-Institutional Antibody and Bioresource Core Facility
Register here.
In-Person Panel: How to Leap into Entrepreneurship
Tuesday, June 18, 2024 - 6:00pm to 8:30pmMaking a change to pursue your dream, turn an idea into a business, and go for it is scary. How have others taken the leap? Hear from a live panel of Cornellians who made the career transition to entrepreneurship. Learn about where they started, their practical and personal processes, and where they are now.
Join us for a networking reception, panel discussion with audience Q&A, and CEN’s trademark “Open Mic,” where YOU can give your 30-second elevator pitch. What better way to start your entrepreneurial journey?!
Featuring:
- Chris Donohoe ’09, Executive Coach (moderator)
- Marissa Saporta ’99, Co-Founder of Gorilla Commerce
- Siwat Siengsanaoh MBA ’15, Co-Founder, Recoup Beverage, Inc.
- Lauren Berson ’04, CEO & Co-Founder, Conceive
Register now.
Idea to Prototype: BioDesign & 3D Printing Workshop
Friday, June 14, 2024 - 3:00pm to 5:00pmBack by popular demand and with the specific aim to cover more intermediate biodesign concepts, this workshop will teach you techniques to generate ideas and physical prototypes for medical device products and education models.
Building on prior 3D printing classes, this program will cover:
- Biodesign concepts to generate ideas
- Expanded 3D printing applications
- Q&A with speakers
Speakers:
NatalieDeana Badillo: 3rd year medical student at Weill Cornell Medicine who possesses a biomedical engineering background. Natalie is also a member of the Biomedical Engineering Society and is President of the Arts & Crafts & 3D Printing Club at Weill Cornell Medicine.
Ana Krieger, M.D., MPH: Chief of Sleep Neurology and Professor of Clinical Medicine in the Departments of Medicine, Neurology and Genetic Medicine at Weill Cornell Medicine. Dr. Krieger is also Co-Founder of BioSleep Technologies and is an experienced user of WCM’s biodesign/3D printing resources.
Register here.
How AI is Transforming Pharmaceutical R&D
Thursday, June 13, 2024 - 4:00pm to 7:00pmThere’s a lot of buzz these days around the role that AI will play in pharmaceutical R&D – from target identification to therapeutic design and optimization, from patient stratification to clinical trial design and site selection, and beyond.
So what’s real, and what’s just hype?
Join JLABS for an engaging panel discussion – featuring representatives from the pharmaceutical industry, the startup world and the investor community – focused on how AI is driving the discovery, development and delivery of innovative medicines today, and what the future holds in this rapidly-evolving space. Followed by an exciting celebratory reception to commemorate JLABS at NYC Six-Year Anniversary!
RSVP here.
I-Corps Regional Course hosted by University of Vermont (Deadline: 6/12/24)
Wednesday, June 12, 2024 - 9:00am to 5:00pmLed by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills.
In this month-long virtual course (July 8 - August 7), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit.
Applications will be reviewed on a rolling basis. Apply now.
Application closes on Wednesday, June 12. Questions? Contact icorps@cornell.edu or visit www.in-icorps.org/regional-courses.
Webinar: Building Your Innovation Support Network
Thursday, June 6, 2024 - 1:00pm to 2:00pmInvent Together presents a virtual discussion with Erin Kelley, Genna Hibbs, and Maria Artunduaga on the importance of building your innovation support network and tips to succeed. Register here.
$100K Biomedical Business Plan Challenge Pitch Event
Tuesday, June 4, 2024 - 5:30pm to 8:30pmJoin the greater Weill Cornell Medicine community for the $100K Biomedical Business Plan Challenge Pitch Event. Faculty-led startups will have completed 10 weeks of rigorous instruction by life science professionals and, with the help of over two dozen industry mentors, created their initial business plans. This event provides an opportunity for the BPC startup teams to pitch their ideas to a group of prominent venture capital judges and compete for up to $100,000 in prize money.
We will kick off the evening at 5:30pm in Uris Auditorium, followed by a celebration of academic entrepreneurship and innovation in Griffis Faculty Lounge. Register here.
CTL@WCM Special Panel: Leveraging Alternatives to Animal Models to Transform Drug Development
Thursday, May 30, 2024 - 12:00pm to 1:00pmA new generation of human model systems are coming to the forefront of drug development, including novel organoid, microphysiological and in silico platforms. With the passage of the FDA Modernization Act 2.0 in 2022, these cutting-edge systems are poised to gain increasing scientific, commercial and regulatory acceptance in replacing data traditionally sought from animal models. But how far can these systems go in displacing animals, and what commercial and regulatory challenges stand in their path?
Join us as we convene a panel of experts in alternative human model systems to discuss their changing role in science and business.
Panelists:
• Lowry Curley, Ph.D., Co-Founder and CEO of Axosim
• Krista Durney, Ph.D., Associate Director, Innovation & Business Development at Valo Health
• Kristin Bircsak, Ph.D., Principal Scientist at MIMETAS
• Iris Bica, Business Development & Licensing Associate at Weill Cornell Medicine (Moderator)
